Pay in 4 interest-free payments of $5.55 Learn more
Ships within 48 hours · Estimated delivery Oct 8 - Oct 13
The drug, which was originally developed at Karuna Therapeutics, began its development journey as an investigational treatment at Eli Lilly for Alzheimers disease, where its effects on the psychotic symptoms of the disease where discovered
Compounded drugs are not FDA-approved, meaning their safety and efficacy remain uncertain
Forceful water injection can denature the peptide and reduce potency
The clinical-scale manufacturing segment is projected to grow at a CAGR of 15.6%, supported by increasing R&D activities involving next-generation GLP-1, dual GIP/GLP-1, and multi-receptor peptide therapeutics
Because copper is a required cofactor for numerous enzymes involved in cellular metabolism and antioxidant activity, researchers studying GHK-Cus copper-binding properties often position it as a tool for understanding copper-dependent signaling pathways generally, not just those specific to skin or tissue repair
US$ 21.16
US$ 21.69
US$ 21.78
US$ 29.24
US$ 21.53
US$ 27.10
US$ 24.58
US$ 22.94
US$ 25.50
US$ 29.40
US$ 20.86
US$ 25.95
